Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 1, 2007, Pages

  MacLeod, R John ^a   Hayes, Madeline ^a   Pacheco, Ivan ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

chemoprevention

Indexed keywords

BETA CATENIN; CALCIUM ION; CHIMERIC ANTIBODY; EXTRACELLULAR CALCIUM SENSING RECEPTOR; FRIZZLED PROTEIN; FRIZZLED8 PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 2; RECOMBINANT PROTEIN; SIAH2 PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ARTICLE; AUTOCRINE EFFECT; CANCER PREVENTION; CELL STRAIN HT29; COLON CANCER; COLON POLYPOSIS; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR CALCIUM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CELLS, CULTURED; COLONIC NEOPLASMS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE; UBIQUITIN-PROTEIN LIGASES; WNT PROTEINS;

EID: 34547103285     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00119.2007     Document Type: Article

References (56)

1. Bacfico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6: 497-506, 2004.
2. o-sensing receptor. J Biol Chem 271: 110537-110545, 1996.
3. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340: 101-107, 1999.
4. Blanc E, Roux GL, Benard J, Raguenez G. Low expression of Wnt5a gene is associated with high-risk neuroblastoma. Oncogene 24: 1277-1283, 2005.
5. Blanc E, Goldschneider D, Douc-Rasy S, Benard J, Raguenez G. Wnt5a gene expression in malignant human neuroblasts. Cancer Lett 228: 117-123, 2005.
6. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N. The Wingless homolog Wnt5a and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108: 965-973, 2006.
7. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001.
8. Castelo-Branco G, Sousa KM, Bryja V, Pinto L, Wagner J, Arenas E. Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt5a secretion. Mol Cell Neurosci 31: 251-262, 2006.
9. 3. Cancer Res 65: 493-498, 2005.
10. Chakrabarty S, Radjenirane V, Appleman H, Varani J. Extracellular calcium-sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/Tcf activation. Cancer Res 63: 67-71, 2003.
11. 2+-sensing receptor in rat intestine. Am J Physiol Gastrointest Liver Physiol 274: G122-G130, 1998.
12. Chattopadhyay N, Yano S, Tfelt-Hansen J, Rooney P, Kanuparthi D, Bandyopadhyay S, Ren X, Terwilliger E, Brown EM. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 145: 3451-3462, 2004.
13. Chen W, ten Berge D, Brwon J, Ahn S, Hu LA, Miller WE, Caron MG, Barak LS, Nusse R, Lefkowitz RJ. Dishevelled 2 recruits β-arrestin 2 to mediate Wnt5a-stimulated endocytocis of Frizzled 4. Science 301: 1391-1394, 2003.
14. Chen J, Park CS, Tang SJ. Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem 281: 11910-11916, 2006.
15. Cheng SX, Geibel JP, Hebert SC. Extracellular polyamines regulate fluid secretion in rat colonic crypts via the extracellular calcium-sensing receptor. Gastroenterology 126: 148-58, 2004.
16. Dejmek J, Dejmek A, Safholm A, Sjolander A, Andersson T. Wnt5a protein expression in primary Dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65: 9142-9146, 2005.
17. 2+-sensing receptors in intestinal epithelium. Am J Physiol Cell Physiol 273: C1168-C1175, 1997.
18. Gregorieff A, Pinto D, Begthel H, Destree O, Kielman M, Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129: 626-638, 2005.
19. Gonzalez-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM. Wnt proteins induce disheveled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize β-catenin. Mol Cell Biol 24: 4757-4768, 2004.
20. Guo RJ, Huang E, Toshihiko E, Patel N, Sinclair K, Wu J, Klein P, Suh ER, Lynch JP. Cdx1 inhibits human colon cancer cell proliferation by reducing β-catenin/T-cell factor transcriptional activity. J Biol Chem 279: 36865-36875, 2004.
21. Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H, Fan K, Yang K, Lipkin M. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 280: 1074-1079, 1998.
22. Hsieh JC, Rattner A, Smallwood PM, Nathans J. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA 96: 3546-3551, 1999.
23. Ilyas M, Tomlinson IPM, Rowan A, Pignatelli M, Bodmer WF. β-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94: 10330-10334, 1997.
24. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 23: 131-139, 2003.
25. Jonsson M, Smith K, Harris AL. Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton. Br J Cancer 78: 430-438, 1998.
26. Jonsson M, Dejmek J, Bendakl PO, Andersson T. Loss of Wnt5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 62: 409-416, 2002.
27. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T, Brabant G. Wnt5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24: 2144-2154, 2005.
28. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A. Expression of Wnt5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and proliferation. Cancer Res 66: 10439-10448, 2006.
29. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Mol Cell Biol 3: 601-614, 2003.
30. Leandersson K, Riesbeck K, Andersson T. Wnt5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res 34: 3988-3999, 2006.
31. Liao J, Schneider A, Datta NS, McCauley LK. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res 66: 9065-9073, 2006.
32. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufield KL, White RL, Matsunami N. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7: 927-936, 2001.
33. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004.
34. MacLeod RJ, Chattopadhyay N, Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 284: E435-E442, 2003.
35. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol Cell 7: 915-926, 2001.
36. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits β-catenin-Tcf signaling depending on receptor context. PLoS Biol 4: e115, 2006.
37. Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 25: 7461-7468, 2006.
38. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-7954, 1996.
39. Nemeth EF. Calcimimetic and calcilytic drugs: just for parathyroid cells? Cell Calcium 35: 283-289, 2004.
40. Peiris D, Pacheco I, Spencer C, MacLeod RJ. The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 292: G753-G766, 2007.
41. Sancho E, Batile E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20: 695-723, 2004.
42. 2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281: E1267-E1274, 2001.
43. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000.
44. Schulte G, Bryja V, Rawal N, Castelo-Branco G, Sousa KM, Arenas E. Purified Wnt5a increases differentiation of midbrain dopaminergic cells and disheveled phosphorylation. J Neurochem 92: 1550-1553, 2005.
45. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537, 2006.
46. Sen M, Chamorro M, Reifert J, Corr M, Carson DA. Blockade of Wnt5a/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44: 772-781, 2001.
47. Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. Am J Gastroenterol 100: 390-394, 2005.
48. Slusarski DC, Corces VG, Moon RT. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signaling. Nature 390: 410-413, 1997.
49. Smith K, Bui TD, Poulson R, Kaklamanis L, Williams G, Harris AL. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer 81:496 -502, 1999.
50. Tfelt-Hansen J, Ferreira A, Yano S, Kanuparthi D, Romero JR, Brown EM, Chattopadhyay N. Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells. Am J Physiol Endocrinol Metab 288: E1206-E1213, 2005.
51. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt5a inhibits the canonical Wnt pathway by promoting GSK-3 independent β-catenin degradation. J Cell Biol 162: 899-908, 2003.
52. Umbhauer M, Djiane A, Goisset C, Penzo-Mendez A, Riou JF, Boucaut JC, Shi DL. The C-terminal cytoplasmic Lys-Thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/β-catenin signaling. EMBO J 19: 4944-4954, 2000.
53. Weeratna AT, Jiang Y, Hosletter G, Rosenblatt K, Duray P, Bittner M, Trent JM. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288, 2002.
54. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanaufusa H, Takada R, Takada S, Nishida E. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 3: 69-75, 2002.
55. Yano S, MacLeod RJ, Chattopadhyay N, Tfelt-Hansen J, Kifor O, Butters RR, Brown EM. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor transactivation. Bone 35: 664-672, 2004.
56. Ziegelstein RC, Xiong Y, He C, Hu Q. Expression of a functional extracellular calcium-sensing receptor in human aortic endothelial cells. Biochem Biophys Res Commun 342: 153-163, 2006.